Previous studies have shown the regulating effect of adrenergic receptor antagonist drugs against cancer initiation and progression due to their influence on the cAMP/PKA, MAPK/ERK, and PI3K/Akt pathways [75,76]. The gene discussed is AKT1; the disease is cancer.